April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Relationships between clinical features, molecular classification, 4-gene mutation profile and outcomes in uveal melanoma
Author Affiliations & Notes
  • Daniel L Chao
    Ocular Oncology Service, Bascom Palmer Eye Inst, Univ of Miami, Miami, FL
  • J William Harbour
    Ocular Oncology Service, Bascom Palmer Eye Inst, Univ of Miami, Miami, FL
  • Footnotes
    Commercial Relationships Daniel Chao, None; J William Harbour, Castle Biosciences (C), Castle Biosciences (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1286. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Daniel L Chao, J William Harbour; Relationships between clinical features, molecular classification, 4-gene mutation profile and outcomes in uveal melanoma. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1286.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To analyze the relationships between clinical features, gene expression profile (GEP) molecular classification, and mutation status of four driver mutations in uveal melanoma.

Methods: 70 primary untreated uveal melanomas underwent GEP classification and mutational analysis for GNAQ, GNA11, BAP1, SF3B1 mutations. GEP and mutation status were analyzed for association with patient age and sex, tumor diameter and thickness, ciliary body involvement, extraocular tumor extension, histological cell type, and metastasis.

Results: GNAQ and GNA11 mutations were found in a mutually exclusive fashion in 85% of samples. BAP1 mutations were found almost exclusively in class 2 tumors and were associated with class 2 GEP, older patient age, ciliary body involvement, increased tumor diameter and thickness and epithelioid cell type. SF3B1 mutations were inversely associated with class 2 GEP, BAP1 mutations, and epithelioid cell type.

Conclusions: The relationships between GEP classification and the four driver mutations point out the two major pathways of uveal melanoma progression (class 1/SF3B1 versus class 2/BAP1 pathways), and provide a basis for rational drug selection for treating metastatic uveal melanoma.

Keywords: 539 genetics • 624 oncology • 744 tumors  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×